Literature DB >> 15063106

Effects of testosterone on body composition of the aging male.

Shiyama Mudali1, Adrian S Dobs.   

Abstract

The aging process is accompanied by significant changes in body composition characterized by decreased fat free mass and increased and redistributed fat mass. Muscle loss results from the atrophy of muscle fibers and decreased synthesis of muscle proteins. Increased number of adipocytes and fat accumulation in non-adipose tissue leads to adiposity. These changes can impose functional limitations and increase morbidity. In men, declining testosterone levels that occur with aging can be a contributing factor to these changes. Studies in hypogonadal men have shown that testosterone replacement is effective in increasing muscle mass and strength and decreasing fat mass. The molecular mechanisms of testosterone's influence on muscle and adipose are not fully elucidated. However, testosterone appears to stimulate IGF-1 expression directly and indirectly leading to increased muscle protein synthesis and growth. It may also counter the inhibitory effects of myostatin, cytokines, and glucocorticoids. The predominant effects of testosterone on fat mass are increased lipolysis and decreased adipogenesis. Current evidence suggests that testosterone replacement may be effective in reversing age-dependent body composition changes and associated morbidity. However, hypogonadism must be diagnosed carefully, and therapy should be monitored regularly in order to avoid the adverse effects associated with testosterone supplementation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063106     DOI: 10.1016/j.mad.2004.01.004

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  21 in total

1.  Sex hormones differentially influence voluntary running activity, food intake and body weight in aging female and male rats.

Authors:  J Andries Ferreira; Andrea M Foley; Marybeth Brown
Journal:  Eur J Appl Physiol       Date:  2011-12-15       Impact factor: 3.078

Review 2.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

3.  Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.

Authors:  D Boey; S Lin; T Karl; P Baldock; N Lee; R Enriquez; M Couzens; K Slack; R Dallmann; A Sainsbury; H Herzog
Journal:  Diabetologia       Date:  2006-04-21       Impact factor: 10.122

Review 4.  Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.

Authors:  Rita Rastogi Kalyani; Mark Corriere; Luigi Ferrucci
Journal:  Lancet Diabetes Endocrinol       Date:  2014-03-06       Impact factor: 32.069

5.  Gender-specific pleiotropic bone-muscle relationship in the elderly from a nationwide survey (KNHANES IV).

Authors:  J H Huh; M K Song; K H Park; K J Kim; J E Kim; Y M Rhee; S-K Lim
Journal:  Osteoporos Int       Date:  2013-10-23       Impact factor: 4.507

Review 6.  The role of androgens and estrogens on healthy aging and longevity.

Authors:  Astrid M Horstman; E Lichar Dillon; Randall J Urban; Melinda Sheffield-Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

Review 7.  Sarcopenia - pathophysiology and clinical relevance.

Authors:  Michael Drey
Journal:  Wien Med Wochenschr       Date:  2011-07-29

Review 8.  Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape.

Authors:  Sylvia Santosa; Michael D Jensen
Journal:  Horm Mol Biol Clin Investig       Date:  2014-10

9.  Stochastic variation of transcript abundance in C57BL/6J mice.

Authors:  Peter T Vedell; Karen L Svenson; Gary A Churchill
Journal:  BMC Genomics       Date:  2011-03-30       Impact factor: 3.969

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.